A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section

NCT02046499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2021-03-09

No results posted yet for this study

Summary

This is a randomized trial comparing oxytocin versus oxytocin + syntometrine in the prevention of post partum haemorrhage in patients undergoing caesarean section

Conditions

  • Prevention of Post Partum Haemorrhage

Interventions

DRUG

Oxytocin

Oxytocin will be administered intravenously as per standard protocol

DRUG

Oxytocin ergometrine

Oxytocin ergometrine will be administered intra-musculalry

Sponsors & Collaborators

  • University of Pretoria

    lead OTHER

Principal Investigators

  • Leon C Snyman, MbChB MMed · Department Obstetrics & Gynaecology, University of Pretoria, South Africa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2014-06-30
Completion
2014-09-30

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02046499 on ClinicalTrials.gov